Xlife Sciences (Switzerland) Performance
| XLS Stock | 26.20 1.50 5.42% |
The firm maintains a market beta of 0.94, which attests to possible diversification benefits within a given portfolio. Xlife Sciences returns are very sensitive to returns on the market. As the market goes up or down, Xlife Sciences is expected to follow. At this point, Xlife Sciences AG has a negative expected return of -0.0615%. Please make sure to check out Xlife Sciences' sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Xlife Sciences AG performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Xlife Sciences AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Xlife Sciences is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Total Cashflows From Investing Activities | -7 M |
Xlife |
Xlife Sciences Relative Risk vs. Return Landscape
If you would invest 2,900 in Xlife Sciences AG on September 3, 2024 and sell it today you would lose (280.00) from holding Xlife Sciences AG or give up 9.66% of portfolio value over 90 days. Xlife Sciences AG is producing return of less than zero assuming 4.3985% volatility of returns over the 90 days investment horizon. Simply put, 39% of all stocks have less volatile historical return distribution than Xlife Sciences, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Xlife Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xlife Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Xlife Sciences AG, and traders can use it to determine the average amount a Xlife Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.014
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | XLS |
Estimated Market Risk
| 4.4 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Xlife Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xlife Sciences by adding Xlife Sciences to a well-diversified portfolio.
Xlife Sciences Fundamentals Growth
Xlife Stock prices reflect investors' perceptions of the future prospects and financial health of Xlife Sciences, and Xlife Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Xlife Stock performance.
| Return On Equity | 0.2 | |||
| Return On Asset | -0.0247 | |||
| Profit Margin | 56.63 % | |||
| Operating Margin | (15.13) % | |||
| Current Valuation | 211.32 M | |||
| Shares Outstanding | 5.28 M | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 253.18 X | |||
| Revenue | 806.07 K | |||
| EBITDA | (5.1 M) | |||
| Cash And Equivalents | 1.96 M | |||
| Total Debt | 63.47 M | |||
| Book Value Per Share | 39.82 X | |||
| Cash Flow From Operations | (4.32 M) | |||
| Earnings Per Share | 8.15 X | |||
| Total Asset | 480.06 M | |||
About Xlife Sciences Performance
Evaluating Xlife Sciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Xlife Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Xlife Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Xlife Sciences AG performance evaluation
Checking the ongoing alerts about Xlife Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Xlife Sciences AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Xlife Sciences AG generated a negative expected return over the last 90 days | |
| Xlife Sciences AG has high historical volatility and very poor performance | |
| Xlife Sciences AG has high likelihood to experience some financial distress in the next 2 years | |
| Xlife Sciences AG has accumulated about 1.96 M in cash with (4.32 M) of positive cash flow from operations. | |
| Roughly 54.0% of the company outstanding shares are owned by insiders |
- Analyzing Xlife Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Xlife Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Xlife Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Xlife Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Xlife Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Xlife Sciences' stock. These opinions can provide insight into Xlife Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Xlife Stock Analysis
When running Xlife Sciences' price analysis, check to measure Xlife Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xlife Sciences is operating at the current time. Most of Xlife Sciences' value examination focuses on studying past and present price action to predict the probability of Xlife Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xlife Sciences' price. Additionally, you may evaluate how the addition of Xlife Sciences to your portfolios can decrease your overall portfolio volatility.